Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders.
Millar CM, Connor N, Dolan G, Lee CA, Makris M, Wilde J, Winter M, Ironside JW, Gill N, Hill FG. Haemophilia. 2010 Mar; 16(2):305-15.